Initial studies that examined the effect of a PRS on breast cancer risk in BRCA1 and BRCA2 carriers showed the absolute lifetime risk of breast cancer was around 10%–20% greater for carriers in the highest decile of the PRS distribution compared with the lowest.14 The gene discussed is BRCA2; the disease is breast cancer.